Browsing by Author "Cengiz A.B."

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Antifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: Results from the first national point prevalence survey
    (Elsevier Ltd, 2018) Çağlar İ.; Devrim İ.; Özdemir H.; Şahbudak Z.; Sönmez G.; Buyukcam A.; Gulhan B.; Kara A.; Aygun D.F.; Bayram N.; Celebi S.; Çetin B.; Nepesov M.İ.; Yilmaz A.T.; Kepenekli E.; Çiftdogan D.Y.; Acar M.K.; Yayla B.C.; Okumuş C.; Ecevit Z.; Hatipoglu N.; Kuyucu N.; Kosker M.; Sen S.; Karbuz A.; Sutcu M.; Duramaz B.B.; Özen M.; Çiftçi E.; Alabaz D.; Kurugol Z.; Kara A.; Kanik S.; Kilic O.; Oncel S.; Somer A.; Tapisiz A.; Belet N.; Akcan Ö.M.; Türel Ö.; Ozkaya A.; Tezer H.; Cengiz A.B.; İnce E.; Camcioglu Y.; Kocabas E.; Arisoy E.S.; Salman N.
    Objectives: The aim of this point prevalence survey was to evaluate the consumption, indications and strategies of antifungal therapy in the paediatric population in Turkey. Methods: A point prevalence study was performed at 25 hospitals. In addition to general data on paediatric units of the institutes, the generic name and indication of antifungal drugs, the presence of fungal isolation and susceptibility patterns, and the presence of galactomannan test and high-resolution computed tomography (HRCT) results were reviewed. Results: A total of 3338 hospitalised patients were evaluated. The number of antifungal drugs prescribed was 314 in 301 patients (9.0%). Antifungal drugs were mostly prescribed in paediatric haematology and oncology (PHO) units (35.2%), followed by neonatal ICUs (NICUs) (19.6%), paediatric services (18.3%), paediatric ICUs (PICUs) (14.6%) and haematopoietic stem cell transplantation (HSCT) units (7.3%). Antifungals were used for prophylaxis in 147 patients (48.8%) and for treatment in 154 patients (50.0%). The antifungal treatment strategy in 154 patients was empirical in 77 (50.0%), diagnostic-driven in 29 (18.8%) and targeted in 48 (31.2%). At the point of decision-making for diagnostic-driven antifungal therapy in 29 patients, HRCT had not been performed in 1 patient (3.4%) and galactomannan test results were not available in 12 patients (41.4%). Thirteen patients (8.4%) were receiving eight different antifungal combination therapies. Conclusion: The majority of antifungal drugs for treatment and prophylaxis were prescribed in PHO and HSCT units (42.5%), followed by ICUs. Thus, antifungal stewardship programmes should mainly focus on these patients within the availability of diagnostic tests of each hospital. © 2018 International Society for Chemotherapy of Infection and Cancer
  • No Thumbnail Available
    Item
    Education of healthcare personnel working with pediatric patients during covid-19 pandemic within the framework of infection control; [Covid-19 pandemisinde enfeksiyon kontrol çalışmaları çerçevesinde çocuk hastalarla çalışan sağlık personeli eğitimi]
    (AVES, 2020) Oygar P.D.; Büyükçam A.; Bal Z.Ş.; Dalgıç N.; Bozdemir Ş.E.; Karbuz A.; Çetin B.Ş.; Kara Y.; Çetin C.; Hatipoğlu N.; Uygun H.; Aygün F.D.; Törün S.H.; Okur D.Ş.; Çiftdoğan D.Y.; Kara T.T.; Yahşi A.; Özer A.; Demir S.Ö.; Akkoç G.; Turan C.; Salı E.; Şen S.; Erdeniz E.H.; Kara S.S.; Emiroğlu M.; Erat T.; Aktürk H.; Gürlevik S.L.; Sütçü M.; Aydın Z.G.G.; Atikan B.Y.; Yeşil E.; Güner G.; Çelebi E.; Efe K.; İşançlı D.K.; Durmuş H.S.; Tekeli S.; Karaarslan A.; Bülbül L.; Almış H.; Kaba Ö.; Keleş Y.E.; Yazıcıoğlu B.; Oğuz Ş.B.; Ovalı H.F.; Doğan H.H.; Çelebi S.; Çakır D.; Karasulu B.; Alkan G.; Yenidoğan İ.; Gül D.; Küçükalioğlu B.P.; Avcu G.; Kukul M.G.; Bilen M.; Yaşar B.; Üstün T.; Kılıç Ö.; Akın Y.; Cebeci S.O.; Turgut M.; Yanartaş M.S.; Şahin A.; Arslanoğlu S.; Elevli M.; Öz Ş.K.T.; Hatipoğlu H.; Erkum İ.T.; Demirbuğa A.; Özçelik T.; Sarı E.E.; Akkuş G.; Hatipoğlu S.S.; Dinleyici E.Ç.; Hacımustafaoğlu M.; Özkınay F.; Kurugöl Z.; Cengiz A.B.; Somer A.; Tezer H.; Kara A.
    Objective: In the early stages of any epidemic caused by new emerging pathogens healthcare personnel is subject to a great risk. Pandemic caused by SARS-CoV-2, proved to be no exception. Many healthcare workers died in the early stages of pandemic due to inadequate precautions and insufficient protection. It is essential to protect and maintain the safety of healthcare personnel for the confinement of pandemic as well as continuity of qualified healthcare services which is already under strain. Educating healthcare personnel on appropiate use of personal protective equipment (PPE) is as essential as procuring them. Material and Methods: A survey is conducted on 4927 healthcare personnel working solely with pediatric patients from 32 different centers. Education given on PPE usage were questioned and analyzed depending on age, sex, occupation and region. Results: Among four thousand nine hundred twelve healthcare personnel from 32 different centers 91% (n= 4457) received education on PPE usage. Of those who received education only 36% was given both theoretical and applied education. Although there was no differences among different occupation groups, receiving education depended on regions. Conclusion: It is essential to educate healthcare personnel appropiately nationwidely for the continuity of qualified healthcare services during the pandemic. © 2020, AVES. All rights reserved.
  • No Thumbnail Available
    Item
    SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey
    (Elsevier B.V., 2021) Oygar P.D.; Büyükçam A.; Bal Z.Ş.; Dalgıç N.; Bozdemir Ş.E.; Karbuz A.; Çetin B.Ş.; Kara Y.; Çetin C.; Hatipoğlu N.; Uygun H.; Aygün F.D.; Törün S.H.; Okur D.Ş.; Çiftdoğan D.Y.; Kara T.T.; Yahşi A.; Özer A.; Demir S.Ö.; Akkoç G.; Turan C.; Salı E.; Şen S.; Erdeniz E.H.; Kara S.S.; Emiroğlu M.; Erat T.; Aktürk H.; Gürlevik S.L.; Sütçü M.; Aydın Z.G.G.; Atikan B.Y.; Yeşil E.; Güner G.; Çelebi E.; Efe K.; İşançlı D.K.; Durmuş H.S.; Tekeli S.; Karaaslan A.; Bülbül L.; Almış H.; Kaba Ö.; Keleş Y.E.; Yazıcıoğlu B.; Oğuz Ş.B.; Ovalı H.F.; Doğan H.H.; Çelebi S.; Çakır D.; Karasulu B.; Alkan G.; Yenidoğan İ.; Gül D.; Küçükalioğlu B.P.; Avcu G.; Kukul M.G.; Bilen M.; Yaşar B.; Üstün T.; Kılıç Ö.; Akın Y.; Cebeci S.O.; Bucak I.H.; Yanartaş M.S.; Şahin A.; Arslanoğlu S.; Elevli M.; Çoban R.; Öz Ş.K.T.; Hatipoğlu H.; Erkum İ.T.; Turgut M.; Demirbuğa A.; Özçelik T.; Çiftçi D.; Sarı E.E.; Akkuş G.; Hatipoğlu S.S.; Dinleyici E.Ç.; Hacımustafaoğlu M.; Özkınay F.; Kurugöl Z.; Cengiz A.B.; Somer A.; Tezer H.; Kara A.
    Background: Understanding SARS-CoV-2 seroprevalence among health care personnel is important to explore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future. Methods: We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed. Results: SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19. Conclusions: Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission. © 2021 The Author(s)